Accountable Care Organizations, Bundled Payments, and the Future of Health Care [WEBINAR]
October 11, 2011
Join David Harlow, author of the Health Blawg as he explains what kind of impact Accountable Care Organizations (ACOs) will have on health care providers during this free webinar brought to you by HCPLive.com on Thursday, October 27, 1:00-2:00PM (ET).
Mr. Harlow is a seasoned health care attorney and consultant recognized as an accomplished, innovative and resourceful thought leader in health care law, strategy and policy. His experience in both the public and private sectors over the past twenty years affords him a unique perspective on legal, policy and business issues facing the health care community. Health care organizations -- including providers, vendors, and payors -- and other health care related businesses, of all shapes and sizes, rely on him to help them navigate the maze of regulatory and business issues facing them on a daily basis. To read more about Mr. Harlow's credentials, click here.
HCPLive recently had the opportunity to catch up with Mr. Harlow at the Health 2.0 Conference, and he was kind enough to give us a quick preview of what will be covered in this webinar.
Please note that there is no CME/CE available for attendees.
Otezla (apremilast) is an oral, selective phosphodiesterase 4 (PDE4) inhibitor for the treatment of patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate.
New research indicates that doctors who treat anaphylaxis with intravenous epinephrine rather than intramuscular or subcutaneous injections are increasing the risk that patients will suffer overdoses or other adverse reactions.
Patients taking statin medication while in the hospital for a hemorrhagic stroke are more than four times more likely to survive than people who aren't taking the drugs, according to a new study. The findings were published online Sept. 22 in JAMA Neurology.
Based on data from the first nine months of the Ebola virus disease epidemic, the numbers of cases are predicted to continue increasing, according to a study published online Sept. 23 in the New England Journal of Medicine.